vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and First Bancorp, Inc (FNLC). Click either name above to swap in a different company.
First Bancorp, Inc is the larger business by last-quarter revenue ($25.8M vs $21.2M, roughly 1.2× Autolus Therapeutics plc). First Bancorp, Inc runs the higher net margin — 39.4% vs -373.3%, a 412.7% gap on every dollar of revenue. First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
AUTL vs FNLC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $25.8M |
| Net Profit | $-79.1M | $10.2M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 48.1% |
| Net Margin | -373.3% | 39.4% |
| Revenue YoY | — | 17.5% |
| Net Profit YoY | 3.6% | 39.7% |
| EPS (diluted) | $-0.30 | $0.91 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $25.8M | ||
| Q3 25 | $21.2M | $24.5M | ||
| Q2 25 | $20.9M | $22.5M | ||
| Q1 25 | $9.0M | $21.8M | ||
| Q4 24 | — | $22.0M | ||
| Q3 24 | $0 | $20.5M | ||
| Q2 24 | $0 | $19.2M | ||
| Q1 24 | $10.1M | $18.5M |
| Q4 25 | — | $10.2M | ||
| Q3 25 | $-79.1M | $9.1M | ||
| Q2 25 | $-47.9M | $8.1M | ||
| Q1 25 | $-70.2M | $7.1M | ||
| Q4 24 | — | $7.3M | ||
| Q3 24 | $-82.1M | $7.6M | ||
| Q2 24 | $-58.3M | $6.2M | ||
| Q1 24 | $-52.7M | $6.0M |
| Q4 25 | — | 48.1% | ||
| Q3 25 | -337.9% | 45.2% | ||
| Q2 25 | -292.6% | 43.7% | ||
| Q1 25 | -726.3% | 39.3% | ||
| Q4 24 | — | 39.5% | ||
| Q3 24 | — | 44.6% | ||
| Q2 24 | — | 38.8% | ||
| Q1 24 | -384.1% | 39.3% |
| Q4 25 | — | 39.4% | ||
| Q3 25 | -373.3% | 37.0% | ||
| Q2 25 | -229.0% | 35.8% | ||
| Q1 25 | -781.1% | 32.5% | ||
| Q4 24 | — | 33.1% | ||
| Q3 24 | — | 36.9% | ||
| Q2 24 | — | 32.1% | ||
| Q1 24 | -522.1% | 32.5% |
| Q4 25 | — | $0.91 | ||
| Q3 25 | $-0.30 | $0.81 | ||
| Q2 25 | $-0.18 | $0.72 | ||
| Q1 25 | $-0.26 | $0.63 | ||
| Q4 24 | — | $0.66 | ||
| Q3 24 | $-0.31 | $0.68 | ||
| Q2 24 | $-0.22 | $0.55 | ||
| Q1 24 | $-0.24 | $0.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | — |
| Total DebtLower is stronger | — | $95.5M |
| Stockholders' EquityBook value | $265.5M | $283.1M |
| Total Assets | $661.9M | $3.2B |
| Debt / EquityLower = less leverage | — | 0.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $86.1M | — | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $95.5M | ||
| Q3 25 | — | $95.5M | ||
| Q2 25 | — | $95.0M | ||
| Q1 25 | — | $70.0M | ||
| Q4 24 | — | $95.0M | ||
| Q3 24 | — | $95.0M | ||
| Q2 24 | — | $70.0M | ||
| Q1 24 | — | $70.0M |
| Q4 25 | — | $283.1M | ||
| Q3 25 | $265.5M | $274.6M | ||
| Q2 25 | $346.5M | $265.5M | ||
| Q1 25 | $371.1M | $259.7M | ||
| Q4 24 | — | $252.5M | ||
| Q3 24 | $477.0M | $256.8M | ||
| Q2 24 | $527.8M | $244.7M | ||
| Q1 24 | $582.0M | $242.6M |
| Q4 25 | — | $3.2B | ||
| Q3 25 | $661.9M | $3.2B | ||
| Q2 25 | $721.0M | $3.2B | ||
| Q1 25 | $746.3M | $3.2B | ||
| Q4 24 | — | $3.2B | ||
| Q3 24 | $827.5M | $3.1B | ||
| Q2 24 | $853.6M | $3.1B | ||
| Q1 24 | $901.4M | $3.0B |
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.36× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.38× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.29× | ||
| Q1 24 | — | 0.29× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $37.8M |
| Free Cash FlowOCF − Capex | $-72.3M | $34.6M |
| FCF MarginFCF / Revenue | -341.2% | 133.9% |
| Capex IntensityCapex / Revenue | 20.8% | 12.5% |
| Cash ConversionOCF / Net Profit | — | 3.72× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $55.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $37.8M | ||
| Q3 25 | $-67.9M | $12.9M | ||
| Q2 25 | $-72.8M | $7.4M | ||
| Q1 25 | $-75.6M | $2.2M | ||
| Q4 24 | — | $26.0M | ||
| Q3 24 | $-76.7M | $9.8M | ||
| Q2 24 | $-51.1M | $6.4M | ||
| Q1 24 | $-40.5M | $-1.5M |
| Q4 25 | — | $34.6M | ||
| Q3 25 | $-72.3M | $12.6M | ||
| Q2 25 | $-80.1M | $7.2M | ||
| Q1 25 | $-83.8M | $828.0K | ||
| Q4 24 | — | $24.6M | ||
| Q3 24 | $-86.3M | $9.6M | ||
| Q2 24 | $-51.9M | $6.3M | ||
| Q1 24 | $-41.0M | $-1.8M |
| Q4 25 | — | 133.9% | ||
| Q3 25 | -341.2% | 51.4% | ||
| Q2 25 | -382.6% | 32.1% | ||
| Q1 25 | -933.1% | 3.8% | ||
| Q4 24 | — | 111.7% | ||
| Q3 24 | — | 47.0% | ||
| Q2 24 | — | 32.9% | ||
| Q1 24 | -406.8% | -9.8% |
| Q4 25 | — | 12.5% | ||
| Q3 25 | 20.8% | 1.2% | ||
| Q2 25 | 34.8% | 0.6% | ||
| Q1 25 | 91.8% | 6.2% | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | 5.3% | 1.8% |
| Q4 25 | — | 3.72× | ||
| Q3 25 | — | 1.42× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.03× | ||
| Q1 24 | — | -0.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
